PW Medtech Group Limited (FRA:PWE)
Germany · Delayed Price · Currency is EUR 0.1230
0.00 (0.00%)
Last updated: Jan 30, 2026, 8:14 AM CET
PW Medtech Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 146.56 | 150.78 | 153.18 | 106.04 | 739.12 | 631.81 |
Depreciation & Amortization | 135.66 | 117.73 | 98.24 | 78.58 | 31.41 | 28.43 |
Other Amortization | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0 |
Loss (Gain) From Sale of Assets | 0.11 | 0.11 | 7.14 | 0.01 | -731.79 | 1.53 |
Asset Writedown & Restructuring Costs | 1.18 | 1.18 | 0.06 | 11.65 | 52.59 | 3.7 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -552.9 |
Loss (Gain) on Equity Investments | - | - | - | - | - | -113.41 |
Stock-Based Compensation | 18.6 | 18.6 | - | - | - | - |
Provision & Write-off of Bad Debts | -2.67 | -2.67 | -4.17 | -2.72 | 1.14 | 14.44 |
Other Operating Activities | -62.7 | -14.48 | -23.24 | 57.2 | -66.98 | 6.46 |
Change in Accounts Receivable | 13.95 | 13.95 | -11.49 | -28.46 | 3.71 | 78.59 |
Change in Inventory | 15.24 | 15.24 | -4.57 | -5.46 | 5.86 | -2.66 |
Change in Accounts Payable | 7.4 | 7.4 | 5.65 | 40.42 | 2.82 | -17.15 |
Change in Unearned Revenue | 10.58 | 10.58 | -5.09 | 7.26 | -0.64 | -0.64 |
Operating Cash Flow | 283.92 | 318.43 | 211.03 | 269.23 | 37.24 | 78.2 |
Operating Cash Flow Growth | 5.17% | 50.89% | -21.62% | 622.91% | -52.38% | -21.79% |
Capital Expenditures | -80.93 | -56.5 | -47.31 | -52.46 | -11.32 | -7.88 |
Sale of Property, Plant & Equipment | 1.25 | 0.55 | 3.7 | 0.11 | 0.14 | 4.52 |
Cash Acquisitions | - | - | - | -1,014 | - | - |
Divestitures | - | - | 35.99 | - | - | - |
Sale (Purchase) of Intangibles | -18.42 | -15.58 | -34.61 | -9.4 | - | - |
Sale (Purchase) of Real Estate | - | 0.82 | - | - | - | - |
Investment in Securities | -79.8 | -0.25 | 0.73 | 48.83 | 2,770 | 2,068 |
Other Investing Activities | 45.99 | 50.65 | 43.83 | 35.37 | 57.34 | 5.55 |
Investing Cash Flow | -131.91 | -20.32 | -26.67 | -1,082 | 2,636 | 2,070 |
Long-Term Debt Issued | - | 5.8 | - | - | - | 18 |
Total Debt Issued | 12.2 | 5.8 | - | - | - | 18 |
Long-Term Debt Repaid | - | -1.5 | -0.67 | -83.64 | -28.42 | -585.73 |
Total Debt Repaid | -1.93 | -1.5 | -0.67 | -83.64 | -28.42 | -585.73 |
Net Debt Issued (Repaid) | 10.28 | 4.3 | -0.67 | -83.64 | -28.42 | -567.73 |
Issuance of Common Stock | 1.25 | - | - | - | - | - |
Repurchase of Common Stock | -75.92 | -80.22 | - | -3.06 | - | - |
Common Dividends Paid | -134.37 | -134.37 | -71.6 | - | -2,062 | - |
Other Financing Activities | -0.58 | -0.37 | 89.8 | 1.54 | -0.6 | -10.66 |
Financing Cash Flow | -199.34 | -210.66 | 17.53 | -85.16 | -2,091 | -578.4 |
Foreign Exchange Rate Adjustments | 7.55 | 4.89 | 5.84 | -4.6 | 0.63 | -0.64 |
Net Cash Flow | -39.78 | 92.33 | 207.74 | -902.86 | 582.99 | 1,569 |
Free Cash Flow | 202.99 | 261.93 | 163.73 | 216.77 | 25.92 | 70.33 |
Free Cash Flow Growth | -8.47% | 59.98% | -24.47% | 736.25% | -63.14% | 33.68% |
Free Cash Flow Margin | 24.03% | 34.06% | 24.25% | 40.38% | 9.55% | 28.43% |
Free Cash Flow Per Share | 0.14 | 0.17 | 0.10 | 0.14 | 0.02 | 0.04 |
Cash Interest Paid | 0.58 | 0.37 | 0.15 | 0.46 | 0.6 | 10.66 |
Cash Income Tax Paid | 42.74 | 36.97 | 44.56 | 14.33 | 7.01 | 2.22 |
Levered Free Cash Flow | -9.6 | 229.94 | 233.51 | -236.55 | 2,229 | -2,123 |
Unlevered Free Cash Flow | -9.23 | 230.17 | 233.6 | -236.26 | 2,229 | -2,116 |
Change in Working Capital | 47.17 | 47.17 | -15.5 | 13.76 | 11.74 | 58.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.